Angiotensin-receptor blockade, cancer, and concerns.

Suppr

超能文献

作者信息

Böhm Michael, Laufs Ulrich, Pfreundschuh Michael

出版信息

Lancet Oncol. 2010 Sep;11(9):818-9; author reply 821-2. doi: 10.1016/S1470-2045(10)70162-5.

DOI:10.1016/S1470-2045(10)70162-5

PMID:20816376

Abstract

摘要

相似文献

Angiotensin-receptor blockade, cancer, and concerns.

Lancet Oncol. 2010 Sep;11(9):818-9; author reply 821-2. doi: 10.1016/S1470-2045(10)70162-5.

Angiotensin-receptor blockade, cancer, and concerns.

Lancet Oncol. 2010 Sep;11(9):820-1; author reply 821-2. doi: 10.1016/S1470-2045(10)70159-5.

Angiotensin-receptor blockade, cancer, and concerns.

Lancet Oncol. 2010 Sep;11(9):819; author reply 821-2. doi: 10.1016/S1470-2045(10)70163-7.

Angiotensin-receptor blockade, cancer, and concerns.

Lancet Oncol. 2010 Sep;11(9):819-20; author reply 821-2. doi: 10.1016/S1470-2045(10)70178-9.

[Angiotensin II type 1 receptor blockade and risk of cancer].

Ugeskr Laeger. 2010 Nov 1;172(44):3054; discussion 3054.

Angiotensin-receptor blockade, cancer, and concerns.

Lancet Oncol. 2010 Sep;11(9):817-8; author reply 821-2. doi: 10.1016/S1470-2045(10)70160-1.

Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be?

Clin J Am Soc Nephrol. 2006 Sep;1(5):1046-8. doi: 10.2215/CJN.00540206. Epub 2006 Jul 19.

Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.

Prescrire Int. 2005 Oct;14(79):180-6.

Use of angiotensin receptor blockers and the risk of cancer.

Circulation. 2011 Apr 26;123(16):1729-36. doi: 10.1161/CIRCULATIONAHA.110.007336. Epub 2011 Apr 11.

Lack of deleterious interaction between angiotensin receptor blockers and beta-blockers in the treatment of patients with heart failure.

J Cardiovasc Pharmacol Ther. 2006 Jun;11(2):149-52. doi: 10.1177/1074248406289916.

引用本文的文献

Does outcome reporting bias "cause" cancer? Risks associated with hidden data on Angiotensin receptor blockers.

Can J Hosp Pharm. 2012 Sep;65(5):387-93. doi: 10.4212/cjhp.v65i5.1177.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Angiotensin-receptor blockade, cancer, and concerns.

Lancet Oncol. 2010 Sep;11(9):818-9; author reply 821-2. doi: 10.1016/S1470-2045(10)70162-5.

Angiotensin-receptor blockade, cancer, and concerns.

Lancet Oncol. 2010 Sep;11(9):820-1; author reply 821-2. doi: 10.1016/S1470-2045(10)70159-5.

Angiotensin-receptor blockade, cancer, and concerns.

Lancet Oncol. 2010 Sep;11(9):819; author reply 821-2. doi: 10.1016/S1470-2045(10)70163-7.

Angiotensin-receptor blockade, cancer, and concerns.

Lancet Oncol. 2010 Sep;11(9):819-20; author reply 821-2. doi: 10.1016/S1470-2045(10)70178-9.

[Angiotensin II type 1 receptor blockade and risk of cancer].

Ugeskr Laeger. 2010 Nov 1;172(44):3054; discussion 3054.

Angiotensin-receptor blockade, cancer, and concerns.

Lancet Oncol. 2010 Sep;11(9):817-8; author reply 821-2. doi: 10.1016/S1470-2045(10)70160-1.

Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be?

Clin J Am Soc Nephrol. 2006 Sep;1(5):1046-8. doi: 10.2215/CJN.00540206. Epub 2006 Jul 19.

Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.

Prescrire Int. 2005 Oct;14(79):180-6.

Use of angiotensin receptor blockers and the risk of cancer.

Circulation. 2011 Apr 26;123(16):1729-36. doi: 10.1161/CIRCULATIONAHA.110.007336. Epub 2011 Apr 11.

Lack of deleterious interaction between angiotensin receptor blockers and beta-blockers in the treatment of patients with heart failure.

J Cardiovasc Pharmacol Ther. 2006 Jun;11(2):149-52. doi: 10.1177/1074248406289916.

引用本文的文献

Does outcome reporting bias "cause" cancer? Risks associated with hidden data on Angiotensin receptor blockers.

Can J Hosp Pharm. 2012 Sep;65(5):387-93. doi: 10.4212/cjhp.v65i5.1177.